In a report released yesterday, Joshua Buchalter from TD Cowen maintained a Buy rating on Texas Instruments, with a price target of $240.00. The company’s shares closed last Tuesday at $196.63.

After several volatile years marked by inflation shocks, rising interest rates and uneven hospital spending, the U.S. medical instrument and medtech sector is entering 2026 on a firmer, yet selective, ...

Performances in N.Y.C. The oboe has 500 parts. Turning a profit is a killer. But Jim Phelan is bent on reviving one of the great names in classical music. Jim Phelan, the owner of the A. Laubin oboe ...

Raleigh, N.C.-based Compass Surgical Partners named Mark Langston as CEO, effective Jan. 5. Mr. Langston previously served as chief development officer at Compass, which partners with physicians and ...

The leadership transition positions ASC partners and the patients they serve for scalable growth. RALEIGH, N.C., Jan. 5, 2026 /PRNewswire/ -- Compass Surgical Partners (Compass) a leading, independent ...

Texas Instruments (TXN) announced that its board of directors has elected President and CEO Haviv Ilan to take on the additional role as chairman, beginning January 2026. Ilan succeeds Rich Templeton, ...

As health care costs climb, hospitals face the challenge of maintaining surgical precision without overspending on supplies. Take a closer look at five trusted names to see how they deliver both value ...

Attorney Les Weisbrod, right, shows X-ray prints that were taken a few days after the surgery of Genaro Nava, left, during a news conference, Wednesday, Aug. 13, 2025, in Dallas. Chitose Suzuki / ...

An AI-powered robot was able to separate the gall bladder from the liver of a dead pig in what researchers claim is the first realistic surgery by a machine with almost no human intervention. The ...

Trump's approval rating for "Big Beautiful Bill" plunges underwater Mel is a Pearly Queen B on her wedding day A flood killed his entire family in 2015. Now he has joined the search in Texas. Anne ...

Bank of America Securities connected with Intuitive Surgical Inc (NASDAQ:ISRG) on reprocessing “noise” in the market. Analyst Travis Steed highlighted that reprocessing is not new to Intuitive, even ...

Deutsche Bank downgraded Intuitive Surgical stock to sell this morning. The banker worries third-party remanufacturers will cut into Intuitive's surgical tools business. Deutsche's new price target ...